Breaking News Instant updates and real-time market news.

FOCS

Focus Financial

$39.99 /

+1.15 (+2.96%)

08:37
11/05/20
11/05
08:37
11/05/20
08:37

Focus Financial reports Q3 adj. EPS 63c, consensus 72c

Reports Q3 revenue $331.48M, consensus $324.57M. "I am extremely pleased with the 2020 third quarter financial and operating results we announced this morning, which again reflected the strength and resiliency of our business," said Rudy Adolf, Founder, CEO and chairman. "Our partner firms continued to do an excellent job managing their businesses, serving their clients and remaining nimble. Our M&A activity increased sharply compared to the prior quarter. That momentum has continued to accelerate in the fourth quarter, and we hit a major milestone of completing more than 200 transactions since our inception, reinforcing our industry leadership and a value proposition that resonates with prospective partner firms and merger candidates alike. We are also taking advantage of the scale and the diversity of our business model to add value to our partner firms in highly innovative ways. I am excited about the prospects for our business in Q4 and into 2021, and the many initiatives we have underway to help our partners better serve their clients and accelerate their growth."

  • 05

    Nov

FOCS Focus Financial
$39.99 /

+1.15 (+2.96%)

08/04/20 Truist
Focus Financial price target raised to $50 from $30 at Truist
06/30/20 Goldman Sachs
Focus Financial upgraded to Buy from Neutral at Goldman Sachs
06/22/20 Credit Suisse
Focus Financial Partners initiated with an Outperform at Credit Suisse
05/21/20 BofA
Focus Financial Partners double-upgraded to Buy from Underperform at BofA

TODAY'S FREE FLY STORIES

Hot Stocks
Moderna appoints Paul Burton as chief medical officer » 08:14
06/14/21
06/14
08:14
06/14/21
08:14
MRNA

Moderna

$218.69 /

+1.59 (+0.73%)

, JNJ

Johnson & Johnson

$164.99 /

-2.065 (-1.24%)

Moderna (MRNA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

Hot Stocks
Teledyne FLIR wins Pentagon contract to develop chemical detectors » 08:13
06/14/21
06/14
08:13
06/14/21
08:13
TDY

Teledyne

$423.96 /

+2.215 (+0.53%)

Teledyne FLIR, part of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDY Teledyne
$423.96 /

+2.215 (+0.53%)

TDY Teledyne
$423.96 /

+2.215 (+0.53%)

06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
01/05/21 Canaccord
FLIR Systems downgraded to Hold from Buy at Canaccord
TDY Teledyne
$423.96 /

+2.215 (+0.53%)

TDY Teledyne
$423.96 /

+2.215 (+0.53%)

Recommendations
Nike price target lowered to $170 from $175 at UBS » 08:13
06/14/21
06/14
08:13
06/14/21
08:13
NKE

Nike

$131.93 /

+0.96 (+0.73%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

05/13/21
Fly Intel: Top five analyst initiations
05/13/21 BofA
Nike reinstated with a Neutral at BofA
05/11/21
Fly Intel: Top five analyst upgrades
05/11/21 Jefferies
Jefferies upgrades Nike to Buy with sportswear 'on fire' and showing no slowing
NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

Hot Stocks
Mack-Cali Realty sells Red Bank office portfolio for $84M » 08:12
06/14/21
06/14
08:12
06/14/21
08:12
CLI

Mack-Cali Realty

$17.93 /

+0.045 (+0.25%)

Mack-Cali Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

04/19/21 Deutsche Bank
Mack-Cali Realty price target lowered to $13 from $14 at Deutsche Bank
12/10/20 Citi
Citi opens '90-day negative Catalyst Watch' on Mack-Cali Realty
08/04/20
Fly Intel: Top five analyst downgrades
08/04/20 Deutsche Bank
Mack-Cali Realty downgraded to Hold from Buy at Deutsche Bank
CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

Hot Stocks
Magenta Therapeutics appoints Thomas Beetham as chief legal officer » 08:12
06/14/21
06/14
08:12
06/14/21
08:12
MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, KNSA

Kiniksa

$14.85 /

+0.02 (+0.13%)

Magenta Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

03/18/21 Evercore ISI
Kiniksa sNDA looks to be approved by FDA, says Evercore ISI
11/24/20 Evercore ISI
Kiniksa initiated with an Outperform at Evercore ISI
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
07/17/20 JPMorgan
Kiniksa risk/reward attractive into Phase 2 data, says JPMorgan
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

  • 22
    Jul
  • 25
    Jun
KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

Hot Stocks
Lordstown Motors sinks 13% to $9.91 after CEO, CFO resign  08:11
06/14/21
06/14
08:11
06/14/21
08:11
RIDE

Lordstown Motors

$11.40 /

+0.795 (+7.50%)

 
ShowHide Related Items >><<
RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
06/08/21 RBC Capital
Lordstown Motors initiated with an Underperform at RBC Capital
05/28/21
Fly Intel: Top five analyst initiations
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

Recommendations
Tesla price target lowered to $812 from $974 at Canaccord » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
TSLA

Tesla

$609.92 /

-0.16 (-0.03%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
06/08/21 Wedbush
Tesla China numbers rebound in 'big way,' says Wedbush
TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

Hot Stocks
Iridium names Greg Pelton as new Chief Technical Officer » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
IRDM

Iridium

$39.05 /

-0.34 (-0.86%)

Iridium announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

IRDM Iridium
$39.05 /

-0.34 (-0.86%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

Hot Stocks
Standard Lithium announces early conversion of loan facility with LANXESS » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
STLHF

Standard Lithium

$3.10 /

+0.035 (+1.14%)

Standard Lithium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

01/12/21 Canaccord
Standard Lithium initiated with a Speculative Buy at Canaccord
Initiation
Procore initiated with a Buy, $100 target at Canaccord » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
PCOR

Procore

$83.98 /

-2.47 (-2.86%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$83.98 /

-2.47 (-2.86%)

07:21 Today JPMorgan
Procore initiated with an Overweight at JPMorgan
07:04 Today William Blair
Procore initiated with an Outperform at William Blair
06:21 Today Canaccord
Procore initiated with a Buy at Canaccord
06:15 Today Oppenheimer
Procore initiated with an Outperform at Oppenheimer
  • 20
    May
PCOR Procore
$83.98 /

-2.47 (-2.86%)

PCOR Procore
$83.98 /

-2.47 (-2.86%)

Hot Stocks
Addus HomeCare announces Robby Stevenson as Chief Human Resource Officer » 08:09
06/14/21
06/14
08:09
06/14/21
08:09
ADUS

Addus HomeCare

$90.89 /

-1.33 (-1.44%)

Addus HomeCare announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

Hot Stocks
Aligos Therapeutics: CAM candidate, STOPS candidate complete Phase 1a studies » 08:08
06/14/21
06/14
08:08
06/14/21
08:08
AGLS

Aligos Therapeutics

$19.38 /

+ (+0.00%)

Aligos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Phunware set to join Russell Microcap Index » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
PHUN

Phunware

$1.40 /

+0.02 (+1.45%)

Phunware is set to join…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

PHUN Phunware
$1.40 /

+0.02 (+1.45%)

05/11/21 Roth Capital
Phunware initiated with a Buy at Roth Capital
06/16/20 Ascendiant
Ascendiant starts Phunware with Buy rating, $4 price target
06/16/20 Ascendiant
Phunware initiated with a Buy at Ascendiant
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

  • 12
    Feb
Hot Stocks
Lipocine: FDA Clears LPCN 1154 IND application for Phase 2 postpartum study » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
LPCN

Lipocine

$1.33 /

+0.065 (+5.16%)

Lipocine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
  • 26
    Jan
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

Initiation
Original Bark Company initiated with a Buy at Canaccord » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
BARK

Original Bark Company

$11.87 /

-0.5 (-4.04%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Jefferies
Barkbox initiated with a Buy at Jefferies
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

Hot Stocks
Rapt Therapeutics reports 'positive' results from Phase 1b RPT193 trial » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
RAPT

Rapt Therapeutics

$18.57 /

-0.15 (-0.80%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
03/12/21 H.C. Wainwright
Rapt Therapeutics price target raised to $32 from $30 at H.C. Wainwright
11/17/20 BMO Capital
Rapt Therapeutics price target lowered to $45 from $51 at BMO Capital
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

Hot Stocks
Twist Bioscience collaborates with Regeneron for genotyping assay production » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
TWST

Twist Bioscience

$114.75 /

+2.95 (+2.64%)

, REGN

Regeneron

$525.71 /

-6.63 (-1.25%)

Twist Bioscience (TWST)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Twist Bioscience initiated with a Neutral at Goldman Sachs
05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

07:32 Today Argus
Regeneron's multiple bullish signals suggest return to growth, says Argus
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

  • 03
    Dec
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

Hot Stocks
Clever Leaves to join Russell Microcap Index » 08:06
06/14/21
06/14
08:06
06/14/21
08:06
CLVR

Clever Leaves

$11.44 /

+0.63 (+5.83%)

Clever Leaves announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

Earnings
Motorcar Parts reports Q4 EPS 4c, consensus 64c » 08:06
06/14/21
06/14
08:06
06/14/21
08:06
MPAA

Motorcar Parts

$23.24 /

-0.09 (-0.39%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

02/04/21 B. Riley Securities
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

Hot Stocks
IMAC acquires Fort Pierce Chiropractic for undisclosed amount » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
IMAC

IMAC

$1.98 /

-0.045 (-2.23%)

IMAC Holdings announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAC IMAC
$1.98 /

-0.045 (-2.23%)

IMAC IMAC
$1.98 /

-0.045 (-2.23%)

04/09/21 Alliance Global Partners
IMAC price target lowered to $2.35 from $3.10 at Alliance Global Partners
11/17/20 Alliance Global Partners
IMAC initiated with a Buy at Alliance Global Partners
IMAC IMAC
$1.98 /

-0.045 (-2.23%)

  • 18
    Jun
Hot Stocks
iCAD's ProFound AI DBT receives CE Mark approval » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
ICAD

iCAD

$18.48 /

+0.1 (+0.54%)

iCAD announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

ICAD iCAD
$18.48 /

+0.1 (+0.54%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley Securities
iCAD price target raised to $23 from $18 at B. Riley Securities
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

  • 03
    Mar
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

Hot Stocks
Happiness Biotech unit signs agreement to distribute Volkswagen EVs » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
HAPP

Happiness Biotech

$1.67 /

-0.02 (-1.18%)

, VWAGY

Volkswagen

$36.21 /

+0.21 (+0.58%)

Happiness Biotech (HAPP)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAPP Happiness Biotech
$1.67 /

-0.02 (-1.18%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

HAPP Happiness Biotech
$1.67 /

-0.02 (-1.18%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

05/20/21 Citi
Volkswagen resumed with a Buy at Citi
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/07/21 JPMorgan
Volkswagen price target lowered to EUR 245 from EUR 255 at JPMorgan
05/07/21 RBC Capital
Volkswagen price target raised to EUR 290 from EUR 277 at RBC Capital
VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

Hot Stocks
Exelixis, Bristol-Myers enter supply agreement for STELLAR-002 trial » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
EXEL

Exelixis

$22.98 /

+0.01 (+0.04%)

, BMY

Bristol-Myers

$67.35 /

-0.03 (-0.04%)

, NKTR

Nektar

$17.62 /

-0.22 (-1.23%)

Exelixis (EXEL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

NKTR Nektar
$17.62 /

-0.22 (-1.23%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

05/25/21 Stifel
Exelixis' COSMIC-021 cohort 6 results 'incrementally negative,' says Stifel
05/18/21 Goldman Sachs
Exelixis assumed with a Sell at Goldman Sachs
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
NKTR Nektar
$17.62 /

-0.22 (-1.23%)

05/18/21 Goldman Sachs
Nektar assumed with a Neutral at Goldman Sachs
02/22/21 Benchmark
Nektar downgraded to Hold on valuation at Benchmark
02/22/21 Benchmark
Nektar downgraded to Hold from Buy at Benchmark
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

NKTR Nektar
$17.62 /

-0.22 (-1.23%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

Hot Stocks
MDC Partners receives revised offer from Stagwell Media » 08:03
06/14/21
06/14
08:03
06/14/21
08:03
MDCA

MDC Partners

$5.58 /

+0.26 (+4.89%)

MDC Partners announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDCA MDC Partners
$5.58 /

+0.26 (+4.89%)

MDCA MDC Partners
$5.58 /

+0.26 (+4.89%)

Hot Stocks
GCM Grosvenor announces $85M upsizing of term loan » 08:02
06/14/21
06/14
08:02
06/14/21
08:02
GCMG

GCM Grosvenor

$10.20 /

-0.33 (-3.13%)

GCM Grosvenor announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

04/23/21 JPMorgan
JPMorgan double upgrades GCM Grosvenor on improved fundraising
04/23/21 JPMorgan
GCM Grosvenor upgraded to Overweight from Underweight at JPMorgan
12/14/20 JPMorgan
GCM Grosvenor initiated with an Underweight at JPMorgan
11/30/20 William Blair
GCM Grosvenor initiated with an Outperform at William Blair
GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.